ArticleDiabetes2026
Adipose Tissue Overexpression of Nicotinamide Phosphoribosyltransferase Prevents Metabolic Dysfunction in Obese Mice via Extracellular Vesicles.
Article in Diabetes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Exercise-Induced Extracellular Vesicles as Mediators of Mitochondrial Biogenesis and Insulin Sensitivity in Metabolic Adaptation.Endocrinology, diabetes & metabolism · 2026Review
Corrections and comments
- Update of
Authors and funding
21 authors.
Funding
Abstract
Nicotinamide phosphoribosyltransferase (NAMPT) maintains the cellular NAD+ pool, and diminished adipocyte NAMPT activity has been implicated in aging- and obesity-related metabolic dysfunction. We generated adipocyte-specific NAMPT overexpressing (ANOV) mice and examined their metabolic phenotypes. Male ANOV mice were protected from high-fat diet-induced metabolic dysfunction, including the development of adipose tissue inflammation and glucose intolerance. In contrast, female ANOV mice were less protected from metabolic dysfunction, possibly due to higher endogenous expression of NAMPT in wild-type female mice. Livers of ANOV mice showed improved insulin signaling, increased NAD+ content, and reduced steatosis, suggesting that NAMPT regulates interorgan communication between adipocytes and hepatocytes. We show that adipose tissue-derived extracellular vesicles (EVs) isolated from ANOV mice enhanced insulin signaling in HepG2 cells and liver and improved glucose tolerance in mice. NAMPT overexpression altered EV cargo composition, including decreased ceramides and increased content of NAD+ and NAMPT. Treating HepG2 cells with an NAMPT inhibitor blunted the effects of ANOV-EV on insulin signaling, suggesting that transfer of NAMPT to recipient cells mediates at least some of the beneficial effects of ANOV-EV. Collectively, these data highlight a novel mechanism by which adipocyte NAMPT regulates systemic metabolic dysfunction via EVs. ARTICLE HIGHLIGHTS: NAD+ is an essential cofactor for many metabolic reactions. Nicotinamide phosphoribosyltransferase (NAMPT) is an important enzyme in NAD+ biosynthesis, and diminished adipocyte NAD+ and NAMPT have been implicated in metabolic dysfunction. Mice with adipocyte NAMPT overexpression (ANOV) were protected from diet-induced metabolic dysfunction, including adipose tissue inflammation, glucose intolerance, and hepatic steatosis. Extracellular vesicles from ANOV mice improved glucose tolerance in obese mice. Compared with wild-type mice, adipose tissue extracellular vesicles from ANOV mice exhibited marked changes in lipid and metabolite cargoes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.